Kozak & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Kozak & Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.07K	Sell	125 -162	-56%	-$9.3K	﹤0.01%	287
2026 Q1	$16.7K	Buy	287 +3	+1%	+$175	﹤0.01%	218
2025 Q4	$15.9K	Hold	284	–	–	﹤0.01%	216
2025 Q3	$13.3K	Buy	284 +146	+106%	+$6.82K	﹤0.01%	229
2025 Q2	$6.58K	Buy	138 +2	+1%	+$98	﹤0.01%	270
2025 Q1	$7K	Buy	136 +1	+0.7%	+$58	﹤0.01%	249
2024 Q4	$7.63K	Buy	135 +20	+17%	+$1.12K	﹤0.01%	262
2024 Q3	$6.12K	Buy	115 +2	+2%	+$94	﹤0.01%	265
2024 Q2	$4.54K	Hold	113	–	–	﹤0.01%	275
2024 Q1	$5K	Buy	113 +3	+3%	+$153	﹤0.01%	275
2023 Q4	$5.52K	Buy	110 +1	+0.9%	+$52	﹤0.01%	271
2023 Q3	$6.19K	Buy	109 +1	+0.9%	+$61	﹤0.01%	269
2023 Q2	$6.97K	Buy	108 +1	+0.9%	+$67	﹤0.01%	255
2023 Q1	$7.44K	Buy	107 +1	+0.9%	+$71	﹤0.01%	253
2022 Q4	$8K	Hold	106	–	–	﹤0.01%	237
2022 Q3	$7K	Buy	106 +1	+1%	+$73	﹤0.01%	242
2022 Q2	$8K	Buy	105 +1	+1%	+$76	0.01%	247
2022 Q1	$7K	Hold	104	–	–	﹤0.01%	285
2021 Q4	$7K	Buy	104 +1	+1%	+$59	﹤0.01%	285
2021 Q3	$6K	Buy	+103	New	+$6.78K	﹤0.01%	267

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kozak & Associates's BMY Position: Q2 2026 in Review

Kozak & Associates reduced its Bristol-Myers Squibb (BMY) stake by 56% in Q2 2026, selling an estimated $9.3K and leaving 125 shares worth $7.07K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Kozak & Associates first reported a position in BMY in Q3 2021 and has held it in 20 quarters since. The position peaked at $16.7K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Kozak & Associates held 125 shares of Bristol-Myers Squibb worth $7.07K as of Q2 2026.
Kozak & Associates sold 162 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.3K.
Bristol-Myers Squibb made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #287 holding.
Kozak & Associates first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 20 quarters since.
Kozak & Associates's Bristol-Myers Squibb position peaked at $16.7K in Q1 2026.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.